Real World Study to Describe the Effectiveness and Safety of Teprotumumab Among Thyroid Eye Disease Patients

NCT07085117 · clinicaltrials.gov ↗
COMPLETED
Status
5
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen